Turning Point Brands TPB Proceeds from maturities of marketable securities

Proceeds from maturities of marketable securities at other companies

EyePoint, Inc. EYPT

$80.93M+76.9%

AbCellera Biologics Inc.ABCL

$143.8M-24.3%

KEE

Keel Infrastructure Corp. Common StockKEEL

$989K-85.7%

NextNavNN

$84M+143%

ZymeworksZYME

$70.18M+50.7%

Oruka Therapeutics, Inc.ORKA

$76.47M-12.3%

Other financials

Income statement

See full

Revenue$124.3M+16.8%

Gross profit$68.3M+14.6%

Operating income$12.5M-46.2%

Net income$11.7M-19.0%

EPS (diluted)$0.60-24.1%

Balance sheet

See full

Cash & equivalents$192.4M+93.1%

Total debt$293.9M+0.3%

Total assets$772.1M+36.8%

Cash flow

See full

Operating cash flow-$22.3M-228%

CapEx$5.1M+135%

Free cash flow-$27.4M-280%

Valuation

See full

Market cap$1.64B+59.0%

Enterprise value$1.74B+42.5%

P/E25.6×+1.5×

P/S3.4×+0.6×

Profitability

See full

Gross margin51.4%+2.3pp

Operating margin21.2%+2.5pp

Net margin13.3%+1.7pp

FCF margin0.4%-14.6pp

Returns & leverage

See full

Return on equity10.9%—

Debt / equity2.6×—

Current ratio5.9×+1.4×

Where this comes from

Reported directly by Turning Point Brands in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities.

The official record: Turning Point Brands’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Turning Point Brands's proceeds from maturities of marketable securities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Turning Point Brands's proceeds from maturities of marketable securities?: Turning Point Brands (TPB) reported proceeds from maturities of marketable securities of $2.35M in Q1 2026.